In addition to their Glycoadvanced feline diet, the pet nutrition company said they will be launching Royal Canin Veterinary Fresh Nutrition later in 2026. The line will feature gently cooked veterinary diets developed by board-certified veterinary nutritionists and will include therapeutic formulations for gastrointestinal and dermatologic conditions
The company also launched home care kits that provide nutritional solutions to support pets that have received a diagnosis related to dermatology, gastrointestinal, and urinary conditions. The kits provide a sampling of diets for those conditions.
According to Royal Canin, the kits are aimed at helping make sure owners follow diet recommendations, as well as bridge the transition between diagnosis and subscription services.1 The company said these kits can also be used as an educational tool that help pet owners better understand the benefits of nutrition compliance.
“VMX sets the tone for the year as we continue to support and empower veterinary professionals through the impact of therapeutic nutrition,” Todd East, DVM, director of veterinary affairs, Royal Canin North America, said in the company release.1 “From our dietary offerings to our ongoing support of learning and development for veterinarians and veterinary technicians, 2026 will continue to be a year of innovation for Royal Canin and commitment to the veterinary industry.”
References
Royal Canin previews upcoming therapeutic innovations at VMX 2026. News release. Royal Canin. January 15, 2026. Accessed January 19, 2026. https://prnmedia.prnewswire.com/news-releases/royal-canin-previews-upcoming-therapeutic-innovations-at-vmx-2026-302660357.htmlRand J, Gottlieb SA. Feline diabetes mellitus. In: Ettinger SJ, Feldman EC, Côté E, eds. Textbook of Veterinary Internal Medicine. 8th ed. Elsevier; 2017:1781-1795.Jørgensen FK, Mohanty A, Kieler IN, et al. Twelve-week controlled caloric restriction with a purpose-formulated diabetic weight loss diet increases achievement of diabetic remission in overweight diabetic cats: an international multicenter prospective, randomized clinical trial. Abstract presented at: 35th ECVIM-CA Congress; September 18-20, 2025; Maastricht, Netherlands.
